Experts call for changes to lung cancer testing for Asian patients

ROUTINE biomarker testing for all non-small cell lung cancer patients in Asia may help to improve diagnosis, experts said.

A new expert consensus published in the Journal of Thoracic Oncology reported that diagnosis and treatment of the most common form of lung cancer in Vietnam and other Asian countries require urgent change to better account for patient characteristics that are unique to the region.